Baropharm Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 51

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 8

Baropharm General Information

Description

Developer of a pharmacy management platform designed to streamline pharmaceutical operations. The company's platform offers wholesale sites into a single integrated system, enabling pharmacies to efficiently order medicines from one location, improving operational efficiency and reducing complexity.

Contact Information

Website
www.baropharm.com
Formerly Known As
Now FarmNet
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Myeongwoo Building, 169 Yeoksam-ro
  • Gangnam-gu
  • Seoul
  • South Korea
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, HealthTech
Corporate Office
  • Myeongwoo Building, 169 Yeoksam-ro
  • Gangnam-gu
  • Seoul
  • South Korea

Baropharm Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baropharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. IPO 29-Aug-2024 Announced Profitable
5. Later Stage VC 29-Aug-2024 Completed Profitable
4. Later Stage VC 14-May-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Sep-2021 Completed Generating Revenue
2. Seed Round 19-Jun-2021 Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2021 Completed Generating Revenue
To view Baropharm’s complete valuation and funding history, request access »

Baropharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baropharm Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
KDB Capital Lender/Debt Provider Minority
SoftBank Ventures Asia Corporate Venture Capital Minority
Company K Partners Venture Capital Minority
KB Securities Investment Bank Minority
Mirae Asset Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Baropharm Acquisitions (1)

Baropharm’s most recent deal was a Merger/Acquisition with Brp Labs. The deal was made on 01-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brp Labs 01-Jan-2023 Merger/Acquisition Drug Discovery
To view Baropharm’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Baropharm Subsidiaries (1)

Company Name Industry Location Founded
Brp Labs Drug Discovery Incheon, South Korea
To view Baropharm’s complete subsidiaries history, request access »

Baropharm FAQs

  • When was Baropharm founded?

    Baropharm was founded in 2019.

  • Where is Baropharm headquartered?

    Baropharm is headquartered in Seoul, South Korea.

  • What is the size of Baropharm?

    Baropharm has 51 total employees.

  • What industry is Baropharm in?

    Baropharm’s primary industry is Enterprise Systems (Healthcare).

  • Is Baropharm a private or public company?

    Baropharm is a Private company.

  • What is Baropharm’s current revenue?

    The current revenue for Baropharm is .

  • How much funding has Baropharm raised over time?

    Baropharm has raised $22.4M.

  • Who are Baropharm’s investors?

    KDB Capital, SoftBank Ventures Asia, Company K Partners, KB Securities, and Mirae Asset Capital are 5 of 8 investors who have invested in Baropharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »